- Email: [email protected]
Erratum to “A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours” [Cancer Treat Rev 40 (2014) 376–389]
Cancer Treatment Reviews 40 (2014) 1037
Contents lists available at ScienceDirect
Cancer Treatment Reviews journal homepage: www.elsevierhealth.com/journals/ctrv
Erratum
Erratum to ‘‘A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours’’ [Cancer Treat Rev 40 (2014) 376–389] Juan W. Valle a, Martin Eatock b, Ben Clueit c, Zahava Gabriel c, Roxanne Ferdinand c, Stephen Mitchell d,⇑ a
Department of Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester, UK Department of Medical Oncology, Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, UK Pfizer UK, Tadworth, Surrey, UK d Abacus International, 6 Talisman Business Centre, Talisman Road, Bicester, Oxfordshire OX26 6HR, UK b c
It was discovered that the original online version of the above article contained errors that were not the fault of the author(s). The Publisher decided to ‘resupply’ (repost and replace) the XML and online PDF of the article. Unfortunately the discovery of the errors was too late to correct the printed issue.
DOI of original article: http://dx.doi.org/10.1016/j.ctrv.2013.08.007
⇑ Corresponding author. Tel.: +44 01869 356681; fax: +44 01869 323248. E-mail address: [email protected] (S. Mitchell). http://dx.doi.org/10.1016/j.ctrv.2014.06.003 0305-7372/Ó 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
Elsevier regrets and apologizes for any inconvenience caused by posting a new version of this article online, but hopes that the reader will understand the reasons for doing so.
Contents lists available at ScienceDirect
Cancer Treatment Reviews journal homepage: www.elsevierhealth.com/journals/ctrv
Erratum
Erratum to ‘‘A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours’’ [Cancer Treat Rev 40 (2014) 376–389] Juan W. Valle a, Martin Eatock b, Ben Clueit c, Zahava Gabriel c, Roxanne Ferdinand c, Stephen Mitchell d,⇑ a
Department of Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester, UK Department of Medical Oncology, Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, UK Pfizer UK, Tadworth, Surrey, UK d Abacus International, 6 Talisman Business Centre, Talisman Road, Bicester, Oxfordshire OX26 6HR, UK b c
It was discovered that the original online version of the above article contained errors that were not the fault of the author(s). The Publisher decided to ‘resupply’ (repost and replace) the XML and online PDF of the article. Unfortunately the discovery of the errors was too late to correct the printed issue.
DOI of original article: http://dx.doi.org/10.1016/j.ctrv.2013.08.007
⇑ Corresponding author. Tel.: +44 01869 356681; fax: +44 01869 323248. E-mail address: [email protected] (S. Mitchell). http://dx.doi.org/10.1016/j.ctrv.2014.06.003 0305-7372/Ó 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
Elsevier regrets and apologizes for any inconvenience caused by posting a new version of this article online, but hopes that the reader will understand the reasons for doing so.